Literature DB >> 15045554

Slipped capital femoral epiphysis: etiology and treatment.

Seiya Jingushi1, Eiji Suenaga.   

Abstract

Progression of slip is apt to cause complications including osteonecrosis and osteoarthritis. Such complications result in a poor prognosis for the joint. Therefore, to diagnose slipped capital femoral epiphysis (SCFE) while it is still mild is important to avoid complications as well as to prevent further slippage. In Japan, as the number of obese patients increases, obesity seems to be involved in the onset of slip both biomechanically and endocrinologically. We need to take care of obese children as they comprise a reservoir for SCFE patients. For severe slip cases, treatment is difficult owing to significant deformity of the femoral head with or without such complications as osteonecrosis and osteoarthritis. Transtrochanteric anterior rotational osteotomy is a promising option for preventing further slippage as well as to improve the congruity of the joint.

Entities:  

Mesh:

Year:  2004        PMID: 15045554     DOI: 10.1007/s00776-003-0755-2

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  4 in total

Review 1.  [Slipped capital femoral epiphysis and overweight].

Authors:  A K Hell
Journal:  Orthopade       Date:  2005-07       Impact factor: 1.087

Review 2.  Evolving Understanding of and Treatment Approaches to Slipped Capital Femoral Epiphysis.

Authors:  James D Wylie; Eduardo N Novais
Journal:  Curr Rev Musculoskelet Med       Date:  2019-06

3.  Long-term outcomes of slipped capital femoral epiphysis treated with in situ pinning.

Authors:  Jolanda J de Poorter; Tom J Beunder; Barzi Gareb; Hubert J Oostenbroek; Gert H J M Bessems; Joris C T van der Lugt; Patrick G M Maathuis; Michiel A J van der Sande
Journal:  J Child Orthop       Date:  2016-07-20       Impact factor: 1.548

4.  Evaluation of the Southwick Angle in Two Hundred Hips of Asymptomatic Children and Adolescents.

Authors:  Felipe Alves Monte; Paulo Sergio Melo; Amaro Alves; José Venâncio Oliveira Junior; George Alencar; Fabio Couto Soares
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2020-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.